- Home
- ROIV vs CHD Comparison
ROIV vs CHD Comparison
Compare ROIV & CHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | CHD |
|---|---|---|
| Founded | 2014 | 1846 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.1B | 23.4B |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ROIV | CHD |
|---|---|---|
| Price | $34.40 | $99.91 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 17 |
| Target Price | $28.94 | ★ $102.18 |
| AVG Volume (30 Days) | ★ 7.1M | 1.2M |
| Earning Date | 05-28-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 1.28% |
| EPS Growth | N/A | ★ 27.43 |
| EPS | N/A | ★ 1.76 |
| Revenue | $8,260,000.00 | ★ $6,203,200,000.00 |
| Revenue This Year | N/A | $0.25 |
| Revenue Next Year | $744.61 | $3.65 |
| P/E Ratio | ★ N/A | $56.70 |
| Revenue Growth | N/A | ★ 1.57 |
| 52 Week Low | $12.28 | $81.33 |
| 52 Week High | $37.97 | $106.04 |
Technical Indicators
Market Signals| Indicator | ROIV | CHD |
|---|---|---|
| Relative Strength Index (RSI) | 45.18 | 51.31 |
| Support Level | $33.01 | $94.79 |
| Resistance Level | $35.70 | $105.18 |
| Average True Range (ATR) | 1.12 | 1.92 |
| MACD | -0.29 | -0.12 |
| Stochastic Oscillator | 20.61 | 64.44 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About CHD Church & Dwight Company Inc.
Church & Dwight is the leading global producer of baking soda. Its portfolio extends beyond its legacy category to include laundry products, cat litter, oral care, deodorant, and nasal care, all sold under the Arm & Hammer brand. Its brands also include Batiste, OxiClean, Vitafusion, Hero, and TheraBreath, which, together with Arm & Hammer, account for around 70% of its annual sales and profits. Most recently, the firm added Touchland and its hand sanitizer business to its fold. Even as it works to expand its product reach, Church & Dwight still derives around 80% of its sales from its home market in the US.